Literature DB >> 22635251

Mapping health status measures to a utility measure in a study of nursing home residents with advanced dementia.

Keith S Goldfeld1, Mary Beth Hamel, Susan L Mitchell.   

Abstract

BACKGROUND: Nursing home residents with advanced dementia commonly experience burdensome and costly interventions (eg, hospitalization) of questionable clinical benefit. To facilitate cost-effectiveness analyses of these interventions, utility-based measures are needed in order to estimate quality-adjusted outcomes.
METHODS: Nursing home residents with advanced dementia in 22 facilities were followed for 18 months (N=319). Validated health status measures ascertained from nurses at baseline, quarterly, and death (N=1702 assessments) were mapped to the Health Utilities Index Mark 2 [range, 1 (perfect health) to 0 (death); scores below 0 indicate states worse than death]. To assess validity, utility scores were compared between residents who did and did not receive burdensome interventions (parenteral therapy, percutaneous endoscopic gastrostomy tubes, and hospital transfers), residents with and without pneumonia, and residents who did and did not die at the last assessment.
RESULTS: Mean (±SD) Health Utilities Index Mark 2 utility score for the cohort was 0.165±0.060 (range, -0.005 to 0.215). Residents spent an average of 15.5% of their days with utilities <0.10. Lower utility scores were found among residents who received burdensome interventions (0.152±0.067 vs. 0.171±0.056; P=0.0003); had pneumonia (0.147±0.066 vs. 0.170±0.057; P=0.003); and were dying (0.163±0.057 vs. 0.180±0.055; P=0.006).
CONCLUSIONS: It is feasible to map health status measures to utility-based measures for advanced dementia. This work will facilitate future cost-effectiveness analyses aimed at quantifying the cost of interventions relative to quality-based outcomes for patients with this condition.

Entities:  

Mesh:

Year:  2012        PMID: 22635251      PMCID: PMC3549579          DOI: 10.1097/MLR.0b013e3182407e0d

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  19 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

2.  Evaluating quality-adjusted life years: estimation of the health utility index (HUI2) from the SF-36.

Authors:  M B Nichol; N Sengupta; D R Globe
Journal:  Med Decis Making       Date:  2001 Mar-Apr       Impact factor: 2.583

3.  Dying with advanced dementia in the nursing home.

Authors:  Susan L Mitchell; Dan K Kiely; Mary Beth Hamel
Journal:  Arch Intern Med       Date:  2004-02-09

Review 4.  A review of quality of life instruments used in dementia.

Authors:  Teake P Ettema; Rose-Marie Dröes; Jacomine de Lange; Gideon J Mellenbergh; Miel W Ribbe
Journal:  Qual Life Res       Date:  2005-04       Impact factor: 4.147

Review 5.  Comparing the incomparable? A systematic review of competing techniques for converting descriptive measures of health status into QALY-weights.

Authors:  Duncan Mortimer; Leonie Segal
Journal:  Med Decis Making       Date:  2008 Jan-Feb       Impact factor: 2.583

6.  The validity and reliability of scales for the evaluation of end-of-life care in advanced dementia.

Authors:  Dan K Kiely; Ladislav Volicer; Joan Teno; Richard N Jones; Holly G Prigerson; Susan L Mitchell
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jul-Sep       Impact factor: 2.703

7.  Quality of life in nursing home residents with advanced dementia.

Authors:  Zachary Cordner; David M Blass; Peter V Rabins; Betty S Black
Journal:  J Am Geriatr Soc       Date:  2010-11-04       Impact factor: 5.562

8.  Dying with advanced dementia in long-term care geriatric institutions: a retrospective study.

Authors:  Paola Di Giulio; Franco Toscani; Daniele Villani; Cinzia Brunelli; Simona Gentile; Patrizia Spadin
Journal:  J Palliat Med       Date:  2008-09       Impact factor: 2.947

9.  The Global Deterioration Scale for assessment of primary degenerative dementia.

Authors:  B Reisberg; S H Ferris; M J de Leon; T Crook
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

10.  The clinical course of advanced dementia.

Authors:  Susan L Mitchell; Joan M Teno; Dan K Kiely; Michele L Shaffer; Richard N Jones; Holly G Prigerson; Ladislav Volicer; Jane L Givens; Mary Beth Hamel
Journal:  N Engl J Med       Date:  2009-10-15       Impact factor: 91.245

View more
  9 in total

1.  The cost-effectiveness of the decision to hospitalize nursing home residents with advanced dementia.

Authors:  Keith S Goldfeld; Mary Beth Hamel; Susan L Mitchell
Journal:  J Pain Symptom Manage       Date:  2013-04-06       Impact factor: 3.612

2.  The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration.

Authors:  Stavros Petrou; Oliver Rivero-Arias; Helen Dakin; Louise Longworth; Mark Oppe; Robert Froud; Alastair Gray
Journal:  Pharmacoeconomics       Date:  2015-10       Impact factor: 4.981

3.  An empirical comparison of the measurement properties of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U for older people in residential care.

Authors:  Tiffany Easton; Rachel Milte; Maria Crotty; Julie Ratcliffe
Journal:  Qual Life Res       Date:  2018-01-05       Impact factor: 4.147

4.  Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.

Authors:  Stavros Petrou; Oliver Rivero-Arias; Helen Dakin; Louise Longworth; Mark Oppe; Robert Froud; Alastair Gray
Journal:  Pharmacoeconomics       Date:  2015-10       Impact factor: 4.981

5.  Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement.

Authors:  Stavros Petrou; Oliver Rivero-Arias; Helen Dakin; Louise Longworth; Mark Oppe; Robert Froud; Alastair Gray
Journal:  Health Qual Life Outcomes       Date:  2015-08-01       Impact factor: 3.186

6.  Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.

Authors:  Stavros Petrou; Oliver Rivero-Arias; Helen Dakin; Louise Longworth; Mark Oppe; Robert Froud; Alastair Gray
Journal:  Appl Health Econ Health Policy       Date:  2015-10       Impact factor: 2.561

7.  Preferred reporting items for studies mapping onto preference-based outcome measures: the MAPS statement.

Authors:  Stavros Petrou; Oliver Rivero-Arias; Helen Dakin; Louise Longworth; Mark Oppe; Robert Froud; Alastair Gray
Journal:  Qual Life Res       Date:  2015-08-01       Impact factor: 4.147

8.  PREFERRED REPORTING ITEMS FOR STUDIES MAPPING ONTO PREFERENCE-BASED OUTCOME MEASURES: THE MAPS STATEMENT.

Authors:  Stavros Petrou; Oliver Rivero-Arias; Helen Dakin; Louise Longworth; Mark Oppe; Robert Froud; Alastair Gray
Journal:  Int J Technol Assess Health Care       Date:  2015-08-03       Impact factor: 2.188

Review 9.  The impact of acute pneumococcal disease on health state utility values: a systematic review.

Authors:  Ryan O'Reilly; Sayako Yokoyama; Justin Boyle; Jeffrey C Kwong; Allison McGeer; Teresa To; Beate Sander
Journal:  Qual Life Res       Date:  2021-07-17       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.